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AbstrACt
Objective The association between tuberculosis (TB), 
diabetes mellitus (DM) and vitamin D status is poorly 
characterised. We therefore: (1) determined vitamin D 
status in patients with TB in relation to whether they had 
normal fasting blood glucose (FBG), pre-DM or DM and 
(2) assessed whether baseline characteristics in patients 
with TB, including their DM status, were associated with 
vitamin D deficiency.
Methods In patients with TB consecutively attending 
six clinics or hospitals in China, we measured 
25-hydroxycholecalciferol (25-(OH)D
3) at the time of 
registration using electrochemiluminescence in a COBASE 
601 Roche analyser by chemiluminescence immunoassay. 
Data analysis was performed using the χ2 test, ORs and 
multivariate logistic regression.
results There were 306 eligible patients with TB, 
including 96 with smear positive pulmonary TB, 187 with 
smear negative pulmonary TB and 23 with extrapulmonary 
TB. Of these, 95 (31%) had normal blood glucose, 83 
(27%) had pre-DM and 128 (42%) had DM. Median serum 
vitamin D levels were 16.1 ng/mL in patients with TB with 
normal FBG, 12.6 ng/mL in patients with TB with pre-DM 
and 12.1 ng/mL in patients with TB with DM (p<0.001). 
The study highlighted certain baseline characteristics 
associated with vitamin D deficiency (25-(OH)D
3<20 ng/
mL). After adjusting for confounders, serum vitamin D 
deficiency was significantly more common in patients 
being registered in the cold season (November to April) 
(p=0.006) and in those with DM (p=0.003).
Conclusion Vitamin D levels are lower in patients with 
TB with pre-DM and DM and are also affected by certain 
baseline characteristics that include being registered in 
the cold season and having DM. TB programmes need to 
pay more attention to vitamin D status in their patients, 
especially if there is coexisting pre-DM or DM.
IntrOduCtIOn
Despite the 47% decline in tuberculosis (TB) 
mortality since 1990, the disease remains a 
major global public health threat. In 2015, 
10.4 million people developed active TB and 
1.4 million people (without HIV infection) 
were estimated to have died from the disease.1 
Successful treatment for TB depends on a 
standardised, supervised 6-month course of 
anti-TB drugs and also on nutritional well-
being and support.1 2
Vitamin D is a secosteroid synthesised in 
the skin by the action of sunlight and also 
ingested in the diet. It has pleiotropic effects 
on many organs and plays a key role in 
human innate and adaptive immunity.3 4 In 
the context of TB, Vitamin D assists mono-
nuclear phagocytes to suppress the intra-
cellular growth of Mycobacterium tuberculosis 
after initial infection.5 6 Vitamin D does this 
by undergoing metabolic activation mainly 
in the liver to 25-hydroxycholecalciferol 
(25-(OH)D3) and then in the kidney to 
strengths and limitations of this study
 ► In contrast to many previous studies on this 
subject in China, the current study enrolled a large 
number of patients with tuberculosis (TB) who were 
consecutively registered in the routine programme 
setting in urban and rural settings.
 ► Rural settings were further divided into non-poverty 
and poverty areas to assess the influence of this 
factor on 25-hydroxycholecalciferol  (25-(OH)D3) 
levels.
 ► Blood samples for measurement of 25-(OH)D3 were 
taken without collecting detailed information about 
the patient’s history, and there is, therefore, no data 
on duration of symptoms or signs which might have 
impacted on vitamin D levels.
 ► The presence or absence of comorbidities that 
affect vitamin D status depended on medical 
documentation or patient self-reports and these 
may have been missed.
 ► 25-(OH)D3 levels were only measured at one time 
before anti-TB treatment and therefore there is no 
information about whether these changed during the 
6-month course of anti-TB treatment.
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1,25-dihydroxycholecalciferol (1,25-(OH)2D3), the latter 
being an immunologically active hormone that stimulates 
antimycobacterial activity in vitro.3 4
Previous reports have shown that people with vitamin 
D deficiency have a significantly higher risk of developing 
active TB compared with those who have normal vitamin D 
levels.3 7 8 This has been particularly observed in migrants 
coming to the UK from Asia.9 Patients with TB have also 
generally been reported to have lower serum levels of 
vitamin D compared with normal controls.10 11 These 
studies have suggested that vitamin D supplementation 
during anti-TB treatment in areas endemic for vitamin 
D deficiency, particularly in poor communities, might 
improve the response to anti-TB treatment. Conversely, 
however, other studies have shown no improved treat-
ment response in terms of sputum culture conversion 
and final treatment outcomes between those receiving 
vitamin D supplementation and those without.9 12 13 These 
conflicting reports beg the question as to whether vitamin 
D deficiency is equally distributed among patients with 
different types and categories of TB or among patients 
with TB with other coexisting comorbidities, such as 
diabetes mellitus (DM).
Persons with DM have three times the risk of devel-
oping active TB compared with normal people, for 
reasons that are not particularly well understood.14 15 
Vitamin D deficiency may play a role in this association.3 16 
Proteomic analysis has suggested that there are qual-
itative differences in the vitamin D-binding protein 
precursor and other proteins between patients with 
TB with and without DM.17 Findings from an interven-
tion study have also shown that when monocyte-derived 
macrophages from patients with DM with low vitamin 
D receptor expression were supplemented with vitamin 
D, the cellular function of eliminating M. tuberculosis 
improved.18
Clinical studies have also been undertaken but have 
shown conflicting results. Chaudhary et al analysed 
vitamin D status, using a radioimmunoassay method, and 
reported no difference in serum vitamin D levels between 
patients with TB and patients with TB with DM, although 
the prevalence of severe vitamin D deficiency was highest 
in the group of patients with DM-TB.19 Conversely, a 
small-scale study in urban China, using liquid chroma-
tography–tandem mass spectrometry, reported signifi-
cant differences in vitamin D levels among patients with 
TB, TB with pre-DM and DM-TB .10 There have been no 
reports of studies looking at associations between vitamin 
D, DM and TB within routine programmatic settings. We 
therefore: (1) determined vitamin D status in patients 
with TB in relation to whether they had normal fasting 
blood glucose (FBG), pre-DM or DM and (2) assessed 
whether baseline characteristics in patients with TB with 




This was a cross-sectional study carried out at six TB clinics 
and hospitals within the routine health services in Jilin 
province, China. Total sample size was calculated using a 
simplified two-sided significance level of 0.05 and a power 
of 0.8. We assumed, based on previous studies, that at 
least 10%–15% of patients with TB in China would have 
serum vitamin D deficiency.20 21 Therefore, the minimum 
required sample size was 62–93. However, taking into 
account poor collection of serum samples in the field 
of 15% and another 20% of blood samples losing their 
quality during long-distance transportation, we needed to 
recruit at least 129 patients with TB. Previous experience 
with this type of work in China has indicated the need 
to add 5% onto the number of recruited patients due to 
missing key information variables and another 10% to 
include different types of TB. Our sample size was there-
fore at least 148 patients with TB.
setting and sites
Previous reports suggested that the prevalence of vitamin 
D deficiency varies depending on the economic situation 
of study subjects’ residential areas.6 Therefore, we selected 
two TB hospitals in urban areas (Liaoyuan City Chest 
Hospital and Tonghua City TB Hospital), three TB clinics 
in non-poverty rural areas (Dongfeng County TB Insti-
tute, Meihekou City TB Institute and Tonghua County TB 
Institute) and one TB clinic in a poverty rural area (Daan 
County TB Institute), a State poverty county streamlined 
by China State Council with an average annual farmers’ 
income of less than US$189. The selection of the clinics 
and hospitals was based on broad economic development 
levels, a sufficient number of patients with TB stratified 
by different types of the disease, the availability of blood 
sample storage facilities and the willingness of the staff to 
participate in the study without incentives.
Patient recruitment
Patients who were consecutively diagnosed and registered 
with TB from November 2015 to July 2016 were included 
in the study. The diagnosis of TB was made in line with 
recommendations from WHO and the China National 
TB Program guidelines.22 23 Patients with suspected TB 
were investigated by sputum smear microscopy. If sputum 
specimens were smear positive for acid-fast bacilli, the 
patient was diagnosed as smear positive pulmonary TB. If 
sputum smears were negative, but the patient had TB-re-
lated symptoms and chest radiography that was compat-
ible with active pulmonary TB, the patient was diagnosed 
as smear negative pulmonary TB after a formal consulta-
tion by physicians. Extrapulmonary TB (EPTB) was diag-
nosed on clinical grounds, using additional circumstantial 
evidence such as radiography, ultrasound and laboratory 
investigations according to the site of the lesion: for a 
diagnosis of EPTB to be made there had to be at least 
one specimen with confirmed M. tuberculosis on smear/
culture or histological evidence of TB or strong clinical 
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and circumstantial evidence consistent with the presence 
of active extrapulmonary disease.
The patients included were ≥18 years and newly regis-
tered with any type and category of TB according to the 
national and international guidelines.22 23 Exclusion 
criteria included: (1) pregnant or lactating women, (2) 
being positive for HIV, (3) having aspartate aminotrans-
ferase or alanine aminotransferase ≥3 times the upper 
limit of normal level as hepatic dysfunction may alter 
vitamin D metabolism, (4) receiving vitamin D or vitamin 
D analogues for any reason, (5) receiving corticoste-
roid treatment for any reason and (6) having cancer or 
receiving anticancer therapy.
blood sample collection
After the patients were registered, 5 mL venous blood 
sample was taken immediately following an overnight fast 
of at least 10 hours. The samples were centrifuged within 
2 hours to separate the serum and stored at −20°C. All 
serum samples were transported to the local Centres for 
Disease Control or blood bank within 7 days and stored at 
−70°C until analysis was undertaken in two single batches.
Vitamin d measurement and definition
The major circulating metabolite of vitamin D is 
25-hydroxycholecalciferol (25-(OH)D3), which was 
measured in the Laboratory Medicine Department 
of Beijing Hospital using the electrochemilumines-
cence method that determines serum 25-(OH)D3 levels 
in a COBASE 601 Roche analyser using a chemilumines-
cence immunoassay. Reagents were supplied from Roche 
with a normal measurement range of 3–70 ng/mL. In 
brief, the assay uses a polyclonal antibody directed against 
25-(OH)D3. Two incubations are required with the spec-
ified reagents, following which the reaction mixture is 
aspirated into a measuring cell where application of a 
voltage to the electrode then induces a chemiluminescent 
emission which is measured by a photomultiplier. Results 
are determined via a calibration curve.24 Holick’s defini-
tions of vitamin D status were used: 25-(OH)D3≥30 ng/
mL=normal; 25-(OH)D3 between 20 and 29.9 ng/mL=in-
sufficient vitamin D; 25-(OH)D3 between 10 and 19.9 ng/
mL=vitamin D deficiency; 25-(OH)D3 between 
0 and 9.9 ng/mL=severe vitamin D deficiency.4
data collection and recording
A standardised questionnaire was developed for data 
collection focusing on demographic characteristics, 
types and categories of TB, symptoms, complications and 
cigarette smoking status. Patients were diagnosed with 
DM either as a result of this being already known (DM 
diagnosed at any time by a registered medical institu-
tion and documented in the clinic notes) or as a result 
of FBG ≥7.0 mmol/L being identified at the time of TB 
registration or at the time of TB diagnosis from another 
health facility. Pre-DM was identified as a result of FBG 
6.1–6.9 mmol/L at the time of TB registration based on 
WHO definition.25 The questionnaire was compiled by 
TB clinic staff and reviewed by the provincial and Union 
staff during monitoring visits and before data entry and 
analysis.
data analysis and statistics
Individual patient data were entered to an EXCEL file 
by the principal investigator. Non-parametric tests (Krus-
kal-Wallis H) were used to compare median levels of 
vitamin D (25-(OH)D3) between groups. Comparisons 
of characteristics of patients with TB between those with 
normal FBG, pre-DM and DM and categorical compar-
isons of various 25-(OH)D3 levels between patients with 
DM, pre-DM and normal FBG were carried out using the 
X2 test. Relationships between 25-(OH)D3 and associated 
exposure variables were evaluated with ORs and 95% 
CIs. We selected variables with unadjusted ORs for which 
the p value was <0.05 and included these in a multivar-
iate logistic regression model using SPSS V.13.0 (SPSS). 
Levels of significance were set at 5%.
ethics approval
The research proposal was reviewed and approved by 
the provincial authorities in the implementing sites. 
The Ethics Advisory Group, International Union Against 
Tuberculosis and Lung Disease, Paris, France, formally 
approved this study (EAG number: 102/15). A written 
informed consent was obtained from participants.
results
There were 317 patients with TB consecutively regis-
tered in this study. Of these, 11 were excluded because 
of insufficient volumes of serum or absence of key infor-
mation variables. Of 306 eligible patients with TB, 96 had 
smear-positive pulmonary TB, 187 had smear-negative 
pulmonary TB and 23 had EPTB. There were 215 men 
and 91 women, aged from 18 to 92 years with a mean of 
51.5 years. Of 306 patients with TB, 95 had normal FBG, 
83 had pre-DM and 128 had DM. The group of patients 
with TB with normal FBG was younger (p<0.001), had 
a higher proportion with rural citizenship (p=0.026), a 
lower proportion with retreatment TB (p=0.016) and a 
higher proportion registered in the months of May to 
October (the warm season) compared with the DM-TB 
group: there no other statistically significant differences 
between the groups (table 1).
Serum vitamin D (25-(OH)D3) levels in patients with 
TB with normal FBG were higher than those found 
in patients with pre-DM-TB and patients with DM-TB 
(table 2). The proportions of patients with vitamin D 
deficiency or severe vitamin D deficiency were 61.1% 
for those with TB and normal FBG, 74.7% for those with 
pre-DM and 83.6% for those with DM (p<0.001) The 
median serum vitamin D levels and their distributions 
in general were similar between Daan county (the rural 
poverty county) and the other sites (p>0.05), although 
there was a higher proportion of patients with normal 
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Table 1 Characteristics of the 306 recruited patients with TB
Characteristics
No (%) of patients with TB
χ2 p Value
Normal FBG Pre-DM DM
(n=95) (n=83) (n=128)
Sex
  Male 69 (72.6) 57 (68.7) 89 (69.5) 0.38 0.82
  Female 26 (27.4) 26 (31.3) 39 (30.5)
Age
  <40 32 (33.7) 20 (24.1) 13 (10.2) 21.4 <0.001
  40–59 42 (44.2) 34 (41.0) 62 (48.4)
  ≥60 21 (22.1) 29 (34.9) 53 (41.4)
Residence
  Urban 25 (26.3) 24 (28.9) 54 (42.2) 7.3 0.03
  Rural 70 (73.7) 59 (71.1) 74 (57.8)
Type/sputum smear
  Positive 33 (34.7) 26 (31.3) 37 (28.9) 2.8 0.6
  Negative 56 (58.9) 48 (57.8) 83 (64.8)
  EPTB 6 (6.4) 9 (10.9) 8 (6.3)
Category of TB
  New 84 (88.4) 64 (77.1) 93 (72.7) 8.29 0.02
  Retreatment 11 (11.6) 19 (22.9) 35 (27.3)
Smoking cigarette/day
  0 44 (46.3) 32 (38.6) 59 (46.1) 10.4 0.11
  1–9 12 (12.6) 19 (22.9) 27 (21.1)
  10–19 22 (23.2) 25 (30.1) 32 (25.0)
  ≥20 17 (17.9) 7 (8.4) 10 (7.8)
Month of TB registration
  May–October 44 (46.3) 34 (41.0) 39 (30.5) 6.16 0.046
  November–April 51 (53.7) 49 (59.0) 89 (69.5)
Poverty area
  Yes 18 (18.9) 14 (16.9) 25 (19.5) 0.25 0.89
  No 77 (81.1) 69 (83.1) 103 (80.5)
May–October=the warm months of the year; November–April=the cold months of the year.
DM, diabetes mellitus; EPTB, extra pulmonary tuberculosis; FBG, fasting blood glucose; Pre-DM, prediabetes mellitus; TB, tuberculosis.
Table 2 Vitamin D status in patients with TB in China, stratified by those with normal FBG, pre-DM and DM
Vitamin D status
Patients with TB with 
normal FBG, 
n=95
Patients with TB 
with pre-DM, 
n=83
Patients with TB 
with DM, 
n=128 p Value
Median level (ng/mL) 16.1 12.6 12.1 <0.01
No (%) with normal level (≥30 ng/mL) 23 (24.2) 8 (9.6) 3 (2.3) <0.001
No (%) with insufficiency (20–29.9 ng/mL) 14 (14.7) 13 (15.7) 18 (14.1) 0.63
No (%) with deficiency (10–19.9 ng/mL) 39 (41.1) 34 (41.0) 69 (53.9) <0.01
No (%) with severe deficiency (≤9.9 ng/mL) 19 (20.0) 28 (33.7) 38 (29.7) 0.041
Vitamin D status determined by measurements of 25-(OH)D3.
25-(OH)D3, 25-hydroxycholecalciferol; DM, diabetes mellitus; FBG, fasting blood glucose; pre-DM, prediabetes diabetes mellitus; TB, 
tuberculosis.
 5Zhao X, et al. BMJ Open 2017;7:e017557. doi:10.1136/bmjopen-2017-017557
Open Access
vitamin D levels residing in areas classified as non-poverty 
(p=0.032) (figure 1).
Baseline characteristics of patients with TB, including 
those with normal FBG, pre-DM and DM in relation to 
having vitamin D deficiency/severe deficiency are shown 
in table 3. After adjusting for confounders with logistic 
regression, the main characteristics associated with having 
a higher risk of vitamin D deficiency were the month of 
TB registration (November to April—the cold months) 
and having DM.
dIsCussIOn
Our study presents findings of vitamin D status among 
different types of patients with TB and in relation to their 
DM status.
First, the median level of vitamin D in patients with 
TB with normal FBG at 16.1 ng/mL was lower than that 
found in the general population (26.3 ng/mL),26 and this 
finding is similar to that reported from other studies.6 10 20 
Once anti-TB treatment is initiated, serum vitamin D levels 
may be further depressed through the action of drugs 
such as rifampicin which increase liver metabolism,27 and 
TB clinic staff need to be made aware of this fact.
Second, serum vitamin D levels in patients with TB 
with pre-DM and with DM were significantly lower than 
in patients with TB with normal FBG, with a similar 
trend having also been found in a small-scale study in 
urban settings of China.10 This was mirrored by the 
higher proportions of patients with pre-DM and DM with 
vitamin D deficiency and severe deficiency compared 
with patients with TB who had normal glucose levels. 
However, these are not consistent observations with a 
report in India finding no significant differences in mean 
vitamin D levels between groups with TB, DM or a combi-
nation of both.19 Both TB and DM can be associated 
with suboptimal nutritional intake, but in this observa-
tional cross-sectional study we were unable to attribute 
any causal association as to whether low vitamin D status 
increases the risk of TB or DM or whether DM or TB 
increases the risk of vitamin D deficiency.
Third, of the six sites participating in this study, one 
was located in an area characterised as a State Poverty 
County streamlined by China State Council. Here, there 
was a significantly lower proportion of patients with TB 
with normal vitamin D status, although the general distri-
bution of vitamin D status from normal to severe defi-
ciency was no different compared with the other sites. It is 
unclear then whether there is any need for interventions 
focused on improving nutritional intake or fortifying 
food with vitamin D supplements in this particular area 
and this needs further discussion.
Fourth, our study highlighted certain characteristics 
associated with vitamin D deficiency in patients with TB. 
Patients with TB registered in the colder months of the 
year (November to April) had a higher risk of vitamin D 
deficiency compared with those registered in the warmer 
months (May to October). This is similar to findings 
observed in Malawi,12 and is possibly due to less sunlight 
and more time spent indoors during winter months.28 The 
study sites were also situated in the north-east of China 
with where the winter season is long and very cold winter 
season. The prices of vegetable, fruit and other food are 
far more expensive than those in the summer time, and 
this may lead to reduced nutritional intake, particularly 
for poor people.
Reports from Vietnam and Afghanistan have found 
gender differences in vitamin D status to be important 
for patients with TB29 30 but this was not observed in our 
study, and this may be due to a relatively higher general 
nutritional status for both men and women in the Chinese 
population.31
Our study also found that DM was an independent risk 
factor for vitamin D deficiency after adjusting for other 
baseline characteristics. A recent study in China found 
that older age, a family history of DM and being over-
weight or underweight were associated with pre-DM and 
TB, with pre-DM itself being a risk factor for the devel-
opment of DM.32 Both DM and TB are associated with 
impaired nutritional intake and this might result in low 
levels of 25-(OH)D3.
33 Among our study subjects, the age 
of patients with TB with DM was generally older than that 
of patients with TB with normal FBG. A previous study in 
China showed that elderly patients with TB experienced 
long delays in accessing health services and this might 
also contribute to poor vitamin D status.34
The strengths of our study were the large number 
of patients with TB enrolled and the consecutive regis-
tration process to prevent selection bias. There were, 
however, some limitations. We took blood samples for 
measurement of 25-(OH)D3 immediately after the diag-
nosis of TB without collecting the patient’s history. We 
therefore do not know the duration of symptoms or signs 
of TB, a factor which might have impacted on serum 
Figure 1 Vitamin D status of patients with tuberculosis in 
the poverty rural area compared with other non-poverty areas 
in China.
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vitamin D levels. The presence or absence of comorbid-
ities depended on medical documentation or patient 
self-reports, so we may have overlooked some conditions 
impacting on vitamin D status because we did not actively 
screen for them. In addition, we only measured 25-(OH)
D3 levels at one time before anti-TB treatment and there-
fore do not know whether these levels changed during 
the 6-month course of anti-TB treatment.
COnClusIOn
Serum vitamin D levels were lower in patients with TB 
with pre-DM and DM compared with those whose FBG 
is normal. Vitamin D levels are also affected by certain 
baseline characteristics, with vitamin D deficiency being 
significantly higher in those with DM and those regis-
tered in the colder months of the year. TB Programmes 
need to pay more attention to vitamin D status in their 
patients, particularly during the cold season and if there 
is coexisting DM or pre-DM.
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(95% CI) p Value
Female 91 65 (71.4) Reference
Male 215 162 (75.3) 1.22 (0.71 to 2.12)
Age
  <40 65 41 (63.1) Reference Reference
  40–59 138 103 (74.6) 1.72 (0.92 to 3.24) 1.30 (0.67 to 2.54) 0.438
 ≥60 103 83 (80.6) 2.43 (1.21 to 4.90) 1.58 (0.75 to 3.34) 0.230
Residence
  Urban 103 75 (72.8) Reference
  Rural 203 152 (74.9) 1.11 (0.65 to 1.91)
Type/sputum smear
  Positive 96 66 (68.8) Reference
  Negative 187 144 (77.0) 1.52 (0.88 to 2.64)
  EPTB 23 17 (73.9) 1.29 (0.46 to 3.59)
Category of TB
  New 241 175 (72.6) Reference
  Retreatment 65 52 (80.0) 1.51 (0.77 to 2.95)
Smoking cigarette/day
  0 135 92 (68.1) Reference
  1–9 58 46 (79.3) 1.79 (0.86 to 3.72)
  10–19 79 60 (75.9) 1.48 (0.79 to 2.77)
  ≥20 34 29 (85.3) 2.71 (0.98 to 7.49)
Month of TB registration
  May–October 117 74 (63.2) Reference Reference
  November–April 189 153 (81.0) 2.47 (1.46 to 4.17) 2.15 (1.25 to 3.69) 0.006
  FBG level
  Normal 95 58 (61.1) Reference Reference
  Pre-DM 83 62 (74.7) 1.88 (0.99 to 3.59) 1.77 (0.91 to 3.43) 0.090
  DM 128 107 (83.6) 3.25 (1.74 to 6.06) 2.68 (1.40 to 5.15) 0.003
p Value is shown for the multivariate adjusted OR.
May–October=the warm months of the year; November–April=the cold months of the year.
Hosmer-Lemeshow good of fit: χ2=7.910, p=0.341, indicating the good of fit of logistic regression models is good.
DM, diabetes mellitus; EPTB, extrapulmonary tuberculosis; FBG, fasting blood glucose; Pre-DM, prediabetes diabetes mellitus; TB, 
tuberculosis.
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